BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 25880630)

  • 21. Study of pharmacokinetic profiles and characteristics of active components and their metabolites in rat plasma following oral administration of the water extract of Astragali radix using UPLC-MS/MS.
    Shi J; Zheng L; Lin Z; Hou C; Liu W; Yan T; Zhu L; Wang Y; Lu L; Liu Z
    J Ethnopharmacol; 2015 Jul; 169():183-94. PubMed ID: 25917840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A sensitive LC-MS/MS method for the quantitative determination of biflorin in rat plasma and its application to pharmacokinetic studies.
    Yang SJ; Ryu JH; Jang DS; Yang L; Han HK
    J Pharm Biomed Anal; 2015 Nov; 115():272-6. PubMed ID: 26263054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats.
    Ezzeldin E; Iqbal M; Al-Salahi R; El-Nahhas T
    J Pharm Biomed Anal; 2019 Mar; 166():244-251. PubMed ID: 30665192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rapid and sensitive UHPLC-MS/MS method for quantification of 83b1 in plasma and its application to bioavailability study in rats.
    Wen D; Guo J; Jiang F; Huang C; Zhao Z; Lu G; Chen J; Qin L; Li Z; Wang X; Deng Z; Huang M; Chi CAS; On TJC; Zhong G
    J Pharm Biomed Anal; 2017 Feb; 134():71-76. PubMed ID: 27886572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitive and specific LC-ESI-MS/MS method for determination of ZYDPLA1, a novel long-acting dipeptidyl peptidase 4 inhibitor in rat plasma: An application for toxicokinetic study in rats.
    Giri P; Patel N; Patel B; Patel H; Bahekar R; Srinivas NR; Patel PR; Desai R
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28370279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of bulleyaconitine A in plasma by a sensitive LC-MS/MS method and its application to an oral pharmacokinetic study in rats.
    Wang Q; Tan B; Gong Y; Ji G; Zhang Y; Yang P; Li W; Shen T
    J Pharm Biomed Anal; 2012 Dec; 71():202-6. PubMed ID: 22980319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender-related pharmacokinetics and bioavailability of a novel anticancer chalcone, cardamonin, in rats determined by liquid chromatography tandem mass spectrometry.
    Jaiswal S; Sharma A; Shukla M; Lal J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():23-30. PubMed ID: 25703949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous determination of a novel oral Janus kinase inhibitor ASP015K and its sulfated metabolite in rat plasma using LC-MS/MS.
    Oda K; Mera K; Nagasaka Y; Tokoro K
    Biomed Chromatogr; 2015 Jul; 29(7):967-9. PubMed ID: 25380383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of an LC-MS/MS method for the determination of DPHB in rat plasma and its application in pharmacokinetic studies.
    Wen Q; Li HL; Chen F; Gong JW; Guan WW; Fu NG; Tan YF
    Biomed Chromatogr; 2018 Dec; 32(12):e4373. PubMed ID: 30133708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of astragaloside III in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic study.
    Zhai Y; Li P; Wang M; Gong M; Qiu F
    Biomed Chromatogr; 2016 Feb; 30(2):105-10. PubMed ID: 26031660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A highly efficient and sensitive LC-MS/MS method for the determination of afatinib in human plasma: application to a metabolic stability study.
    Kadi AA; Abdelhameed AS; Darwish HW; Attwa MW; Al-Shakliah NS
    Biomed Chromatogr; 2016 Aug; 30(8):1248-55. PubMed ID: 26683307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Validation of a Sensitive LC-MS-MS Method for Quantification of Mogrol in Rat Plasma and Application to Pharmacokinetic Study.
    Luo Z; Zhang K; Shi H; Guo Y; Ma X; Qiu F
    J Chromatogr Sci; 2017 Mar; 55(3):284-290. PubMed ID: 27884874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of an LC-MS/MS method for quantification of kadsurenone in rat plasma and its application to a pharmacokinetic study.
    Zhang N; Li R; Yu H; Shi D; Dong N; Zhang S; Wang H
    Biomed Chromatogr; 2013 Dec; 27(12):1754-8. PubMed ID: 23843078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of a sensitive and specific LC-MS/MS method for determination of eriodictyol-8-C-β-d-glucopyranoside in rat plasma for a bioavailability study.
    Qiu F; Fu S; Zhang X; Gong M; Wang M
    Biomed Chromatogr; 2015 Feb; 29(2):220-5. PubMed ID: 24898607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of pharmacokinetics, bioavailability and protein binding of anacetrapib in rats by a simple high-performance liquid chromatography-tandem mass spectrometry method.
    Kim SB; Kim KT; Joo J; Seo KA; Hwang H; Kim SH; Song M; Lee S; Jahn A; Cho HJ; Kim DD; Yoon IS
    Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27432781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative determination of euphol in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.
    Xie X; Li Y; Gao D; Zhang Y; Ren Y
    Biomed Chromatogr; 2014 Sep; 28(9):1229-34. PubMed ID: 25237707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An LC-MS/MS method for determination of curculigoside with anti-osteoporotic activity in rat plasma and application to a pharmacokinetic study.
    Zhao G; Yuan F; Zhu J
    Biomed Chromatogr; 2014 Mar; 28(3):341-7. PubMed ID: 23996522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of an LC-MS/MS method for the determination of SB-505124 in rat plasma: Application to pharmacokinetic study.
    Jiang J; Zhang Y; Zhang Q; Li Y; Gong T; Zhang Z; Ding R; Sun X
    J Pharm Biomed Anal; 2016 Jan; 117():205-9. PubMed ID: 26363490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Validation of a LC-MS/MS Method for Quantification of Mobocertinib (TAK-788) in Plasma and its Application to Pharmacokinetic Study in Rats.
    Li B; Wang J; Dou X; Zhang X; Xue X; Xu Q; Ran W; Xiong S
    Comb Chem High Throughput Screen; 2021; 24(9):1410-1416. PubMed ID: 33155888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.
    Gurav SD; Gilibili RR; Jeniffer S; Giri S; Srinivas NR; Mullangi R
    Biomed Chromatogr; 2011 Jul; 25(7):794-800. PubMed ID: 20872957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.